Bioorganic Chemistry Overview

Principles

Definition

Bioorganic chemistry is an interdisciplinary research field positioned at the interface of organic chemistry and biology, fundamentally concerned with applying chemical principles to understand biological systems. It investigates the molecular basis of biological phenomena through the synthesis, structure, and reactivity of organic molecules in biological contexts, aiming to elucidate biological function and develop novel chemical probes and therapeutic strategies.

Ontological type

Chemical Probes

Core Concepts

Therapeutic Applications

Key developments

Key Figures

Cofactor Mechanistic Foundations era

Arthur Kornberg [1], associated with Harvard University [3] and Stanford University [4], was a central figure in this era. His key contributions include the enzymatic synthesis of deoxyribonucleic acid [6], the incorporation of pyrimidine and purine analogues into deoxyribonucleic acid [5], and the linkage of single deoxynucleotides to the deoxyribonucleoside ends of deoxyribonucleic acid [7], which were pivotal for establishing polymerase-based control of genetic information in this era. Charles C. Richardson [2], linked with Harvard University [3] and Stanford University [4], was another leading figure in this period. His key contribution is the enzymic synthesis of deoxyribonucleic acid [6], which reinforced the integration of enzymology and nucleic acid chemistry central to the Cofactor Mechanistic Foundations era.

Metalloenzyme Structure-Function era

Helmut Sies [1] is a prominent researcher active in the Metalloenzyme Structure-Function era (1976–2008), affiliated with Johns Hopkins University [3] and Albert Einstein College of Medicine [4]. His key contributions include the discovery and characterization of biologically active seleno-organic compounds—1 [7] and IV [8], which advanced understanding of selenium chemistry in redox biology and provided early tools for probing catalytic residues in redox-active systems. F. Peter Guengerich [2] is a leading figure in this era, with affiliations at Harvard University [5] and MIT [6]. His paper "Chemical mechanisms of catalysis by cytochromes P-450: a unified view" [9] articulated a comprehensive mechanism for P-450 catalysis, clarifying how oxygen activation and redox chemistry drive substrate oxidation and underpinning mechanistic and biomimetic approaches in this era.

Synthetic–Computational Lead Design era

Tomislav Rovis [1] is a leading figure in the Synthetic–Computational Lead Design era, with notable affiliations at the University of California, Los Angeles [3] and Princeton University [4]. His key contribution in this era centers on Rh(III)-catalyzed C–H activation to couple benzamides with donor/acceptor diazo compounds to form γ-lactams, as described in the paper A Coupling of Benzamides and Donor/Acceptor Diazo Compounds To Form γ-Lactams via Rh(III)-Catalyzed C–H Activation [7], which showcased direct C–H functionalization enabling rapid heterocycle assembly. Claudiu T. Supuran [2] has affiliations with Harvard University [5] and the Interuniversity Consortium for Magnetic Resonance [6] during this era. In this era, his contributions include the inhibitory effects of isatin Mannich bases on carbonic anhydrases, acetylcholinesterase, and butyrylcholinesterase [8], benzoxaborole as a new chemotype for carbonic anhydrase inhibition [9], and the synthesis of novel sulfamides derived from β-benzylphenethylamines as acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase inhibitors [10], collectively advancing multitarget enzyme inhibition strategies in bioorganic chemistry.